151 related articles for article (PubMed ID: 10942424)
1. CAG tract of MJD-1 may be prone to frameshifts causing polyalanine accumulation.
Gaspar C; Jannatipour M; Dion P; Laganière J; Sequeiros J; Brais B; Rouleau GA
Hum Mol Genet; 2000 Aug; 9(13):1957-66. PubMed ID: 10942424
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts.
Toulouse A; Au-Yeung F; Gaspar C; Roussel J; Dion P; Rouleau GA
Hum Mol Genet; 2005 Sep; 14(18):2649-60. PubMed ID: 16087686
[TBL] [Abstract][Full Text] [Related]
3. Expanded ATXN3 frameshifting events are toxic in Drosophila and mammalian neuron models.
Stochmanski SJ; Therrien M; Laganière J; Rochefort D; Laurent S; Karemera L; Gaudet R; Vyboh K; Van Meyel DJ; Di Cristo G; Dion PA; Gaspar C; Rouleau GA
Hum Mol Genet; 2012 May; 21(10):2211-8. PubMed ID: 22337953
[TBL] [Abstract][Full Text] [Related]
4. Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.
Silva-Fernandes A; Costa Mdo C; Duarte-Silva S; Oliveira P; Botelho CM; Martins L; Mariz JA; Ferreira T; Ribeiro F; Correia-Neves M; Costa C; Maciel P
Neurobiol Dis; 2010 Oct; 40(1):163-76. PubMed ID: 20510362
[TBL] [Abstract][Full Text] [Related]
5. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
[TBL] [Abstract][Full Text] [Related]
6. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells.
Tsai HF; Tsai HJ; Hsieh M
Biochem Biophys Res Commun; 2004 Nov; 324(4):1274-82. PubMed ID: 15504352
[TBL] [Abstract][Full Text] [Related]
7. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
8. Prenatal diagnosis of Machado-Joseph disease/Spinocerebellar Ataxia Type 3 in Taiwan: early detection of expanded ataxin-3.
Tsai HF; Liu CS; Chen GD; Lin ML; Li C; Chen YY; Wang BT; Hsieh M
J Clin Lab Anal; 2003; 17(5):195-200. PubMed ID: 12938149
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Onuf's nucleus in Machado-Joseph disease: a morphometric and immunohistochemical study.
Shimizu H; Yamada M; Toyoshima Y; Ikeuchi T; Onodera O; Takahashi H
Acta Neuropathol; 2010 Oct; 120(4):439-48. PubMed ID: 20503052
[TBL] [Abstract][Full Text] [Related]
10. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
[TBL] [Abstract][Full Text] [Related]
11. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain.
Paulson HL; Das SS; Crino PB; Perez MK; Patel SC; Gotsdiner D; Fischbeck KH; Pittman RN
Ann Neurol; 1997 Apr; 41(4):453-62. PubMed ID: 9124802
[TBL] [Abstract][Full Text] [Related]
12. Compromised mitochondrial complex II in models of Machado-Joseph disease.
Laço MN; Oliveira CR; Paulson HL; Rego AC
Biochim Biophys Acta; 2012 Feb; 1822(2):139-49. PubMed ID: 22037589
[TBL] [Abstract][Full Text] [Related]
13. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
Gonçalves N; Simões AT; Cunha RA; de Almeida LP
Ann Neurol; 2013 May; 73(5):655-66. PubMed ID: 23625556
[TBL] [Abstract][Full Text] [Related]
14. YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit.
Cemal CK; Carroll CJ; Lawrence L; Lowrie MB; Ruddle P; Al-Mahdawi S; King RH; Pook MA; Huxley C; Chamberlain S
Hum Mol Genet; 2002 May; 11(9):1075-94. PubMed ID: 11978767
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous intracellular localization and expression of ataxin-3.
Trottier Y; Cancel G; An-Gourfinkel I; Lutz Y; Weber C; Brice A; Hirsch E; Mandel JL
Neurobiol Dis; 1998 Nov; 5(5):335-47. PubMed ID: 10069576
[TBL] [Abstract][Full Text] [Related]
16. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3.
Berke SJ; Schmied FA; Brunt ER; Ellerby LM; Paulson HL
J Neurochem; 2004 May; 89(4):908-18. PubMed ID: 15140190
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains.
Evert BO; Vogt IR; Kindermann C; Ozimek L; de Vos RA; Brunt ER; Schmitt I; Klockgether T; Wüllner U
J Neurosci; 2001 Aug; 21(15):5389-96. PubMed ID: 11466410
[TBL] [Abstract][Full Text] [Related]
18. Molecular analyses of Machado-Joseph disease.
Kobayashi T; Kakizuka A
Cytogenet Genome Res; 2003; 100(1-4):261-75. PubMed ID: 14526188
[No Abstract] [Full Text] [Related]
19. A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration.
Goti D; Katzen SM; Mez J; Kurtis N; Kiluk J; Ben-Haïem L; Jenkins NA; Copeland NG; Kakizuka A; Sharp AH; Ross CA; Mouton PR; Colomer V
J Neurosci; 2004 Nov; 24(45):10266-79. PubMed ID: 15537899
[TBL] [Abstract][Full Text] [Related]
20. Improvement in the molecular diagnosis of Machado-Joseph disease.
Maciel P; Costa MC; Ferro A; Rousseau M; Santos CS; Gaspar C; Barros J; Rouleau GA; Coutinho P; Sequeiros J
Arch Neurol; 2001 Nov; 58(11):1821-7. PubMed ID: 11708990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
